SHPHShuttle Pharmaceuticals Holdings, Inc.
SHPH holders
Who holds Shuttle Pharmaceuticals Holdings, Inc., from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.
Moves this quarter
Added
- Tower Research Capital LLC (TRC)+1.4K$7.1K
Reduced—
New
- Jane Street Group, LLC19.4K$78.6K
- Geode Capital Management, LLC14.7K$59.4K
- UBS Group AG5.7K$23.1K
- Managers
- 5
- Shares held
- 41.8K
- Value held
- $168.8K
- Opened
- 3
- Closed
- 3
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 19.4K | New | $78.6K | 0% | Nov 12, 2026 |
| Geode Capital Management, LLC | 14.7K | New | $59.4K | 0% | Nov 6, 2026 |
| UBS Group AG | 5.7K | New | $23.1K | 0% | Nov 10, 2026 |
| Tower Research Capital LLC (TRC) | 1.8K | +353.0% | $7.1K | 0.1% | Nov 16, 2026 |
| Kelleher Financial Advisors | 120 | ±0% | $485 | 0.1% | Oct 30, 2026 |